Skip to main navigation Skip to search Skip to main content

Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study - ELITE II

  • Bertram Pitt
  • , Philip Poole-Wilson
  • , Robert Segal
  • , Felipe A. Martinez
  • , Kenneth Dickstein
  • , A. John Camm
  • , Marvin A. Konstam
  • , Gunter Riegger
  • , George H. Klinger
  • , James Neaton
  • , Divakar Sharma
  • , Balasamy Thiyagarajan
  • , Elite II Investigators
  • , Chim C. Lang (Research group member)

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study - ELITE II'. Together they form a unique fingerprint.
    Sort by

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases